Current guidelines on prevention with a focus on dyslipidemias.

Area of Science:

• Cardiology
• Preventive Medicine
• Lipidology

Background:

• Atherosclerotic cardiovascular disease (ASCVD) arises from multiple risk factors including hyperlipidemia, hypertension, and diabetes.
• Current guidelines from ACC/AHA and ESC/EAS address ASCVD prevention and dyslipidemia management.
• Risk calculators are essential for assessing cardiovascular risk in asymptomatic individuals.

Purpose of the Study:

• To compare and contrast the current ACC/AHA and ESC/EAS guidelines for cardiovascular disease prevention and dyslipidemia management.
• To identify commonalities and differences in risk assessment and therapeutic strategies.
• To highlight the importance of simplifying communication for healthcare professionals and the public.

Main Methods:

• Comparative analysis of the ACC/AHA and ESC/EAS guidelines.
• Examination of recommendations for risk factor assessment and management.
• Review of therapeutic approaches, including statin and non-statin therapies.

Main Results:

• Both guidelines emphasize a multifactorial approach to ASCVD risk.
• ACC/AHA guidelines advocate universal statin use in high-risk individuals and primary prevention above 7.5% 10-year risk, focusing on LDL-C reduction.
• ESC/EAS guidelines utilize a goal-based LDL-C reduction strategy tailored to overall risk and baseline levels.

Conclusions:

• Significant common ground exists between ACC/AHA and ESC/EAS guidelines regarding ASCVD prevention and dyslipidemia.
• Both guidelines incorporate risk stratification tools and consider non-statin therapies.
• Simplifying communication and emphasizing shared principles are crucial for effective implementation.